These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Low potential for interactions between melagatran/ximelagatran and other drugs, food, or alcohol. Wolzt M; Sarich TS; Eriksson UG Semin Vasc Med; 2005 Aug; 5(3):254-8. PubMed ID: 16123912 [TBL] [Abstract][Full Text] [Related]
8. Assessing pharmacokinetic and pharmacodynamic interactions in clinical trials of antiepileptic drugs. Reife RA Adv Neurol; 1998; 76():95-103. PubMed ID: 9408466 [TBL] [Abstract][Full Text] [Related]
9. Natural product and drugs interactions, its clinical implication in drug therapy management. Joshi R; Medhi B Saudi Med J; 2008 Mar; 29(3):333-9. PubMed ID: 18327355 [TBL] [Abstract][Full Text] [Related]
10. [Drug metabolism and drug interaction of anxiolytics]. Uchimura N; Etou Y Ryoikibetsu Shokogun Shirizu; 2003; (38):612-6. PubMed ID: 12877062 [No Abstract] [Full Text] [Related]
11. [In vivo effect of food on absorption of fluoroquinolones]. Füredi P; Pápai K; Budai M; Ludányi K; Antal I; Klebovich I Acta Pharm Hung; 2009; 79(2):81-7. PubMed ID: 19634639 [TBL] [Abstract][Full Text] [Related]
12. Systematic overview of warfarin and its drug and food interactions. Holbrook AM; Pereira JA; Labiris R; McDonald H; Douketis JD; Crowther M; Wells PS Arch Intern Med; 2005 May; 165(10):1095-106. PubMed ID: 15911722 [TBL] [Abstract][Full Text] [Related]
13. [Factors influencing activity of oral anticoagulants. Interactions with drugs and food]. Sawicka-Powierza J; Rogowska-Szadkowska D; Ołtarzewska AM; Chlabicz S Pol Merkur Lekarski; 2008 May; 24(143):458-62. PubMed ID: 18634396 [TBL] [Abstract][Full Text] [Related]
14. [Therapeutic drug monitoring: clinical practice]. Widmer N; Werner D; Grouzmann E; Eap CB; Marchetti O; Fayet A; Csajka C; Decosterd LA; Buclin T Rev Med Suisse; 2008 Jul; 4(165):1649-50, 1652-60. PubMed ID: 18767291 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of mood stabilizers and new anticonvulsants. Wang PW; Ketter TA Psychopharmacol Bull; 2002; 36(1):44-66. PubMed ID: 12397847 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects of drug-nutrient interactions in the elderly. Roe DA J Am Diet Assoc; 1985 Feb; 85(2):174-8, 181. PubMed ID: 3918093 [TBL] [Abstract][Full Text] [Related]
18. Food-drug interactions: Careful drug selection and patient counseling can reduce the risk in older patients. Leibovitch ER; Deamer RL; Sanderson LA Geriatrics; 2004 Mar; 59(3):19-22, 32-3. PubMed ID: 15035576 [TBL] [Abstract][Full Text] [Related]
19. Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management. Sokol KC; Knudsen JF; Li MM J Clin Pharm Ther; 2007 Apr; 32(2):169-75. PubMed ID: 17381667 [TBL] [Abstract][Full Text] [Related]
20. [How to identify and prevent pharmacokinetically relevant drug-drug interactions]. Ritter CA Med Monatsschr Pharm; 2009 Oct; 32(10):364-74; quiz 375-6. PubMed ID: 19886226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]